Open Payments

Newyork-Presbyterian/Queens

Type
Teaching hospital
Where
Flushing, NY
Medicare CCN
330055
Received
$487,596 in 90 records, 2023 ($144,111 general, $343,485 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2023General payment56$144,111
2023Research payment34$343,485

By company

CompanyRecordsAmountYears
Gilead Sciences, Inc.8$153,0122023
Boston Scientific Corporation15$94,2492023
Merck Sharp & Dohme LLC1$60,1142023
Novartis Pharmaceuticals Corporation2$54,7602023
ENDOTRONIX, INC.1$43,2762023
Masimo Corporation35$12,3942023
Stryker Corporation6$12,0152023
Chiesi USA, Inc.1$11,7502023
Volta Medical Inc4$9,9862023
Novocure Inc.2$9,4502023
BIOTRONIK INC.3$6,2472023
Medline Industries LP1$4,6252023
Baxter Healthcare1$2,8812023
Abbott Laboratories1$2,5002023
LANTHEUS MEDICAL IMAGING, INC.1$2,5002023
Siemens Medical Solutions USA, Inc.1$2,3102023
KCI USA, Inc.1$1,9502023
Barco, Inc.2$1,9032023
Linvatec Corporation1$8042023
Olympus America Inc.1$5002023
Merit Medical Systems Inc1$2792023
AstraZeneca Pharmaceuticals LP1$852023

By nature of payment

NatureRecordsAmount
Research payment34$343,485
Grant1$95,425
Long term medical supply or device loan39$20,807
Debt forgiveness9$19,611
Space rental or facility fees (teaching hospital only)3$6,000
Food and Beverage3$2,182
Education1$85

Records

DateCompanyAmountNatureFormProductStudyYear
2023-12-31Gilead Sciences, Inc.$95,425GrantCash or cash equivalent2023
2023-12-31Medline Industries LP$4,625Debt forgivenessCash or cash equivalent2023
2023-12-31Stryker Corporation$3,936Long term medical supply or device loanIn-kind items and servicesPRIME SERIES Device, PATIENT HANDLING - PH2023
2023-12-31Stryker Corporation$3,230Long term medical supply or device loanIn-kind items and servicesPRIME SERIES Device, PATIENT HANDLING - PH2023
2023-12-31Stryker Corporation$2,510Debt forgivenessCash or cash equivalent2023
2023-12-31Stryker Corporation$896Debt forgivenessCash or cash equivalent2023
2023-12-31Linvatec Corporation$804Long term medical supply or device loanIn-kind items and servicesMENISCAL REPAIR DEVICES Device, ORTHOPEDIC SURGERY2023
2023-12-31Stryker Corporation$441Long term medical supply or device loanIn-kind items and servicesISOFLEX LAL Device, PATIENT HANDLING - PH2023
2023-12-20Gilead Sciences, Inc.$1,404Research paymentCash or cash equivalentSunlenca Drug, HIVA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2023
2023-12-18Abbott Laboratories$2,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentINFINITY Device, Neuromodulation2023
2023-12-15Barco, Inc.$1,845Food and Beverage (15 payments)In-kind items and services2023
2023-12-11Boston Scientific Corporation$1,380Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$281Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-29Masimo Corporation$25Long term medical supply or device loanCash or cash equivalentSedLine Device, CARDIOVASCULAR2023
2023-11-15Merit Medical Systems Inc$279Food and BeverageCash or cash equivalent2023
2023-10-23Boston Scientific Corporation$4,770Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-10-19ENDOTRONIX, INC.$43,276Research paymentCash or cash equivalentCORDELLA PULOMONARY ARTERY PRESSURE SENSOR Device, HEART FAILUREPROACTIVE-HF2023
2023-10-12LANTHEUS MEDICAL IMAGING, INC.$2,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentDEFINITY Drug, CONTRAST AGENT2023
2023-10-02Boston Scientific Corporation$43,963Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-09-29Barco, Inc.$58Food and Beverage (2 payments)In-kind items and services2023
2023-09-21Volta Medical Inc$2,126Research paymentCash or cash equivalentVX1 Device, CardiovascularTailored AF Study (CLIPL-01-002)2023
2023-08-31BIOTRONIK INC.$4,561Debt forgivenessCash or cash equivalent2023
2023-08-31BIOTRONIK INC.$99Debt forgivenessCash or cash equivalent2023
2023-08-27Baxter Healthcare$2,881Debt forgivenessIn-kind items and services Device, Trauma (Emergency, Injury, Surgery)2023
2023-08-25Gilead Sciences, Inc.$34,000Research paymentCash or cash equivalentVeklury Drug, COVID-19Incidence of Acute Kidney Disease in COVID-19 Patients Receiving Remdesivir2023
2023-08-25Gilead Sciences, Inc.$1,202Research paymentCash or cash equivalentSunlenca Drug, HIVA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2023
2023-08-24Chiesi USA, Inc.$11,750Research paymentCash or cash equivalentA Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Du2023
2023-08-24Novocure Inc.$6,750Research paymentCash or cash equivalentEF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi2023
2023-08-11Boston Scientific Corporation$1,364Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-08-08Boston Scientific Corporation$272Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-07-31AstraZeneca Pharmaceuticals LP$85EducationIn-kind items and servicesIRESSA Drug, Oncology2023
2023-07-17Gilead Sciences, Inc.$12,000Research paymentCash or cash equivalentAcceptability of Long-Acting Injectable Lenacapavir Among Heavily Treatment Experienced Individuals with HIV within the 2023
2023-06-21Gilead Sciences, Inc.$1,404Research paymentCash or cash equivalentSunlenca Drug, HIVA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2023
2023-06-16Boston Scientific Corporation$818Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-06-12Boston Scientific Corporation$3,812Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-06-02Boston Scientific Corporation$272Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-05-15Boston Scientific Corporation$371Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-05-08Boston Scientific Corporation$272Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-05-05Siemens Medical Solutions USA, Inc.$2,310Research paymentCash or cash equivalentPE OUS Study2023
2023-03-30Novocure Inc.$2,700Research paymentCash or cash equivalentEF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi2023
2023-03-24Volta Medical Inc$3,847Research paymentCash or cash equivalentVX1 Device, CardiovascularTailored AF Study (CLIPL-01-002)2023
2023-03-15Merck Sharp & Dohme LLC$60,114Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASESTUDY NAME#Impact of an Acute-Care Antimicrobial Stewardship Program's Interventional Collaboration on Antimicrobial Use2023
2023-03-02Stryker Corporation$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentSURPASS EVOLVE Device, FLOW DIVERTER2023
2023-03-02Masimo Corporation$360Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-03-02Masimo Corporation$360Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-03-02Masimo Corporation$360Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-03-02Masimo Corporation$360Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-02-22Gilead Sciences, Inc.$1,202Research paymentCash or cash equivalentSunlenca Drug, HIVA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2023
2023-02-21Boston Scientific Corporation$16,131Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-02-21Boston Scientific Corporation$4,500Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-02-16KCI USA, Inc.$1,950Debt forgivenessCash or cash equivalentBair Hugger Device, Thermal Regulation Systems & Temp Mgmt Systems2023
2023-02-10Olympus America Inc.$500Debt forgivenessIn-kind items and servicesEVIS EXERA lll COLONOVIDEOSCOPE Device, Gastroenterology2023
2023-02-08Gilead Sciences, Inc.$6,375Research paymentCash or cash equivalentSunlenca Drug, HIVA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2023
2023-02-01Novartis Pharmaceuticals Corporation$18,650Research paymentCash or cash equivalentENTRESTO Drug, Cardiology/Vascular DiseasesProspective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE-HFpEF)2023
2023-01-31BIOTRONIK INC.$1,586Debt forgivenessCash or cash equivalent2023
2023-01-27Volta Medical Inc$1,012Research paymentCash or cash equivalentVX1 Device, CardiovascularTailored AF Study (CLIPL-01-002)2023
2023-01-26Volta Medical Inc$3,000Research paymentCash or cash equivalentVX1 Device, CardiovascularTailored AF Study (CLIPL-01-002)2023
2023-01-26Boston Scientific Corporation$272Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-01-25Novartis Pharmaceuticals Corporation$36,110Research paymentCash or cash equivalentLEQVIO Drug, Cardiology/Vascular DiseasesA randomized, multicenter, open-label trial comparing the effectiveness of an "inclisiran first" implementation strategy2023
2023-01-17Boston Scientific Corporation$15,774Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-01-11Boston Scientific Corporation$272Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX TRENDS2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$432Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$200Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$200Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023
2023-01-01Masimo Corporation$200Long term medical supply or device loanCash or cash equivalentrainbow Acoustic Monitoring Device, CARDIOVASCULAR2023

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

In New York; placed by its state only.

MeasureState
New York
Population B0100319,852,366
Population, 2020 census P120,201,249
Median age B0100239.8
Under 18 B0100120.5%
65 and over B0100117.9%
Households B110017,722,646
Foreign born B0500222.8%
Median household income B19013$85,974
Median family income B19113$106,873
Per capita income B19301$50,712
Poverty rate B1700114.0%
Unemployment rate B230256.4%
Civilian labor force B2302510,171,766
Mean commute (minutes) B0801332.6
Bachelor's degree or higher B1500340.2%
Housing units B250018,585,241
Owner-occupied B2500354.3%
Renters B2500345.7%
Median home value B25077$423,800
Median gross rent B25064$1,621
White, not Hispanic B0300252.8%
Black B0300213.4%
Hispanic or Latino B0300219.8%
Asian B030029.0%
American Indian and Alaska Native B030020.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in New York.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.